Oduah I N, Thabrew M I, Emerole G O
Chem Biol Interact. 1984 May;49(3):299-310. doi: 10.1016/0009-2797(84)90104-2.
In vivo and in vitro experiments have shown that [14C] niridazole ( NDZ ) can covalently bind to the proteins of rat liver, kidney and testes, but not to the DNA in these tissues. The covalent binding was dose dependent, and the greatest amount of binding was found in the microsomal fraction. The binding of [14C] NDZ to microsomal protein was linear with time and with protein concentration. Reduced nicotinamide adenine dinucleotide phosphate was necessary for the binding, while cobaltous chloride pretreatment inhibited it, demonstrating that a cytochrome P-450 dependent mixed function oxidase mediated the binding. Pretreatment of rats with other compounds, such as phenobarbital, 3-methyl-cholanthrene and chloracetamide which alter the rate of metabolism of [14C] NDZ similarly affected the extent of hepatic binding of the radiolabelled metabolite. The possible relationships between these results and the cytotoxic effects of NDZ have been discussed.
体内和体外实验表明,[14C]硝唑咪(NDZ)能与大鼠肝脏、肾脏和睾丸中的蛋白质共价结合,但不与这些组织中的DNA结合。共价结合呈剂量依赖性,且在微粒体部分发现的结合量最大。[14C] NDZ与微粒体蛋白的结合随时间和蛋白浓度呈线性关系。还原型烟酰胺腺嘌呤二核苷酸磷酸是结合所必需的,而氯化钴预处理可抑制该结合,表明细胞色素P-450依赖性混合功能氧化酶介导了这种结合。用其他化合物(如苯巴比妥、3-甲基胆蒽和氯乙酰胺)预处理大鼠,这些化合物会改变[14C] NDZ的代谢速率,同样会影响放射性标记代谢物在肝脏中的结合程度。已讨论了这些结果与NDZ细胞毒性作用之间的可能关系。